Medically reviewed by Dr Sin Yong · Last reviewed · Doctor-performed, never delegated · Jump to questions
Melasma treatment in Singapore starts with diagnosis under the lamp, then strict sun discipline and topicals, then low-energy pico laser in spaced sessions to avoid rebound darkening. Dr Sin Yong explains why melasma is managed rather than removed, and how to keep it quiet.
Aftercare Day-by-day aftercare, what to avoid and when to call
Dr Sin Yong · MBBS (NUS) · MRCS (Edin) · MSc Aesthetic Medicine with Distinction (Queen Mary, London) · MSc Practical Dermatology (Cardiff) · Global Key Opinion Leader
The two commonest pigmentation problems in Singapore look alike — and are treated almost oppositely. Getting the diagnosis right matters more than the technology.

Melasma sits in hormone-sensitive skin and rebounds when hit hard. Dr Sin Yong confirms the diagnosis with a lamp, starts topical treatment and sun discipline, and uses low-energy pico laser in careful sessions rather than one aggressive one.
Sun spots, Hori's naevus and post-inflammatory marks mimic it and are treated differently.
Topical lightening and strict sun protection come before any laser.
Low-fluence pico laser in spaced sessions, reviewed for rebound each time.
Suitability is decided at an in-person assessment. No prices are quoted on this page; fees are given in writing after the assessment. Images and video are illustrative, not patients.
Melasma treatment in Singapore starts with diagnosis, because melasma is a hormonal, chronic, relapsing and heat-sensitive pigmentation that is managed very differently from sun spots (solar lentigines). Dr Sin Yong separates the two at assessment before choosing any device, since an approach suited to one can aggravate the other.
Also called: chloasma, mask of pregnancy, 黄褐斑, 肝斑
Melasma treatment suits patches confirmed as melasma at assessment, and Dr Sin Yong separates melasma from sun spots before any device is chosen. Many patients arrive having already had laser for what they were told was pigmentation; whether that was the right call depends entirely on which pigmentation it was.
Sun spots — solar lentigines — are deposits. They sit where UV has accumulated over years, they have defined borders, and they behave relatively predictably.
Melasma is a different condition altogether. It is hormonal, chronic and relapsing, it is driven by melanocytes that are overactive rather than more numerous, and it is heat-sensitive. It distributes in the centrofacial, malar and mandibular patterns rather than as discrete spots.
The two can coexist on the same face, which is precisely why the assessment separates them before any device is chosen. Other pigmentation types and post-inflammatory hyperpigmentation are separated at the same time.
“Melasma is managed, not cured. A clinic promising a cure is promising a relapse.”
Dr Sin YongOn pigmentation assessment
Singapore sits roughly one degree north of the equator. There is no seasonal low in UV, so the exposure is year-round rather than summer-weighted — which is one reason melasma behaves differently here than it does in temperate advice written for temperate climates.
The less familiar part is heat. Infrared and visible light are triggers in their own right, independent of UV. That means a hot yoga class, a steamy walk to the MRT, a kitchen, or a sunscreen that covers UVB and UVA but not visible light can all contribute. So can a heat-generating laser applied to the wrong diagnosis.
Practical management therefore has to address heat exposure and daily photoprotection alongside whatever is done in clinic. Treatment that ignores the triggers is treating one half of the problem.
“The two commonest pigmentation problems in Singapore look alike and are treated almost oppositely.”
Dr Sin YongOn melasma and sun spots · from his Instagram explainer series


People hoping for a one-off clearance, or unable to commit to daily photoprotection and heat avoidance, tend to respond poorly, because melasma is chronic and relapsing.
Melasma treatment in Singapore is chosen by depth as much as by diagnosis. Pigment sitting in the epidermis, in the dermis, or in both is classed at assessment with dermoscopy and a Wood's lamp. That class decides which of five options carries the plan and which only supports it. The matrix below sets out how each option is used for each depth, and, because heat is itself a melasma trigger, when a laser is more likely to worsen the patch than lighten it. It is a reading aid for the consultation, not a prescription; what is used on your face is decided in person.

| Option | Epidermal melasma | Dermal melasma | Mixed melasma | When laser worsens it | Page |
|---|---|---|---|---|---|
| Tranexamic acid (cream; oral is prescription-only and screened for clotting risk) | A core topical, because it acts on the vascular and inflammatory signalling that keeps melanocytes switched on | Still used, since it targets the driver rather than the deposit, but dermal pigment responds more slowly | Usually part of the plan from the start | Not a laser; it is the layer that is run before any device is considered | Tranexamic acid |
| Hydroquinone cycles (prescription) | Supervised courses with planned breaks, because it slows pigment production at the epidermis | Limited reach; pigment that has dropped into the dermis is not produced there | Used for the epidermal component, in cycles, with maintenance by gentler agents between courses | Not a laser; prolonged unsupervised use carries its own risk (ochronosis), which is why courses are cycled | Hydroquinone |
| Pico toning (low energy) | A cautious adjunct for stable, well-protected melasma, not a first step | Longer wavelength reaches dermal pigment; lowest energy, larger spot, longer intervals, with a stop rule | Adjunct only, after topicals and trigger control have settled the process | High energy, small spots, short intervals, a fresh tan, or toning the same area repeatedly: rebound darkening and pale mottled spots | Pico laser for melasma |
| R2 Glow (long-pulsed 755 and 1064 nm, inflammation-directed) | Considered where the patch flushes, stings or darkens after heat, since it calms the process rather than clearing the deposit | Does not clear dermal deposit; calms the inflammation that keeps producing it | Often the first in-clinic step, before any pigment-directed pass | Any parameters chosen to fragment pigment rather than to calm; R2 Glow is run at inflammation-directed settings | R2 Glow Laser |
| Sun strategy (tinted iron-oxide sunscreen, heat avoidance, indoors near windows) | The baseline every other option depends on | The same; dermal melasma relapses with the same triggers | The same, for as long as the tendency lasts | Laser over unprotected or recently tanned skin adds heat to a trigger-driven condition | Sun and haze in Singapore |
Read across the rows and one pattern stands out: the topical and sun columns carry the plan at every depth, and the two lasers are adjuncts whose place depends on whether the process is calm. That is why a device is never the first step here, and why a patch that darkens after any step is reassessed rather than treated again with more energy. Hori's naevus, which is dermal pigment often mistaken for melasma, follows a different plan; see Hori's naevus (ABNOM).
Melasma treatment at this practice is staggered on purpose: each layer of the plan is started, read at review, and only then built on. The order below is the same for every face; what differs is the pace, which follows the skin.
Before anything is prescribed, the pigment is examined in daylight-balanced and angled light and, where needed, with a dermatoscope and a Wood's lamp. This confirms that the patch is melasma rather than sun spots, post-inflammatory pigment, freckles or Hori's naevus, and classes its depth as epidermal, dermal or mixed. A patch that is changing, raised or unlike the rest is examined first and referred for dermatological assessment where needed. The diagnosis, not the request, sets the protocol.
Trigger control and topical therapy are started first and given time to work before any device is considered. That usually means daily tinted, iron-oxide sunscreen and heat avoidance. It also means prescription agents chosen for the depth found, such as tranexamic acid, hydroquinone in a supervised cycle, or tretinoin, after the medical history has been reviewed. Oral tranexamic acid is considered only after screening for clotting risk. Progress is judged at a review visit rather than week by week, because pigment responds in cycles. Many patches settle enough on this layer that no laser is needed.
Where in-clinic work is appropriate, it is added only to a stable, well-protected patch, and it is sequenced. If the face flushes, stings or darkens after heat, R2 Glow at settings aimed at inflammation comes before any pass aimed at pigment. Picosecond or 1064 nm toning, if used at all, is run at the least energy that still breaks up pigment. That means a longer wavelength, a lower fluence (energy per area), a larger spot and longer intervals, sometimes with a test area first. Toning is not run on an open-ended schedule; the plan has a defined stop point. A patch that darkens or mottles after a pass is a signal to stop and reassess, not to repeat; why that happens is explained in pigmentation worse after laser. Settings are chosen for Fitzpatrick III to V skin, and treatment is deferred over a recent tan or active irritation.
Stopping hydroquinone is planned, not abrupt, with maintenance handed to gentler agents such as azelaic acid, a retinoid or tranexamic acid. Daily sun protection continues indefinitely: a tinted sunscreen for visible light, reapplied through the day, worn indoors near windows, alongside shade and cooling in a climate with no seasonal low in UV. Review checks for rebound, irritation or pale patches and reconsiders hormones and heat before anything further. A return of pigment after a hot season, a pregnancy or a change of hormonal medicine is a known pattern to be reassessed, not proof that the plan failed. How the whole plan is built is on laser toning and pico laser for melasma. Lightening creams bought online, and what HSA has found in them, are covered on laser pigmentation removal.
Network meta-analyses compare many melasma treatments at once. One, covering 39 trials with 1,394 participants, ranked a Q-switched Nd:YAG laser combined with topical medication first, and advised weighing side effects, skin type and how long the melasma has been present. A second concluded that combination treatment outperforms any single treatment.

A 2024 meta-analysis of randomised trials found that tranexamic acid reduced melasma severity scores, most with the oral form, followed by injections and topical use. Results varied widely between studies, and side effects included stomach upset, skin irritation and menstrual changes. Tranexamic acid is a prescription medicine and is considered only after a medical consultation. Melasma tends to return, which is why treatment is staggered and maintained.
The sequence below describes phases, not a timetable: how quickly each passes depends on the settings used, the area and the person, and is discussed at consultation.

The sun rules, topical schedule and rebound signs are set out in the melasma treatment aftercare guide; the Bahasa Melayu guide is melasma dan pigmentasi.
The fee follows the plan, not a fixed list. It depends on what the assessment finds, since epidermal, dermal and mixed patterns are managed differently, and on the area involved, from a limited malar patch to a centrofacial distribution. It also reflects whether topical care, trigger control and in-clinic work are combined, and how the plan is staged. A written quote is given at consultation, after assessment, before anything is agreed. The consultation also decides whether treatment is advised at all.

How quotes work at this practice: how we quote. What to declare and bring to the first visit is on the consultation process page.
| How many sessions | Topical treatment for 8–12 weeks first; then 4–6 low-energy pico sessions, 3–4 weeks apart; maintenance every 2–3 months. |
| Downtime | None to a day of mild redness; no peeling with low-energy settings. |
| How long it lasts | Melasma is controlled, not cured: it returns with sun, heat and hormones unless maintenance continues. |
Figures are typical ranges from Dr Sin Yong's practice and the published literature; your plan, including the number of sessions, is set after the assessment and may differ. Fees are given in writing after the assessment: see how we quote.
Melasma is driven by sun and visible light, heat, hormones and genetics. Treatment lightens pigment but does not remove the tendency, so it returns when triggers continue.
Sun and visible-light protection every day; prescription creams; oral tranexamic acid where suitable; and gentle, low-energy laser in spaced sessions. Aggressive laser can make melasma worse.
After clearing, maintenance creams and occasional gentle laser keep it controlled. Summer and pregnancy can bring flares.
| Treatment | Role | Notes |
|---|---|---|
| Sunscreen with visible-light protection | Prevents darkening | Daily |
| Prescription creams | Lightens pigment | Weeks to months |
| Oral tranexamic acid | Reduces pigment activity | If suitable, after screening |
| Low-energy laser | Lightens gently | Spaced sessions |
Leave your name, mobile number and email and the clinic will contact you directly.
See a doctor if patches appeared or deepened in pregnancy or after starting hormonal medicine, if they became darker after a laser or peel, or if a lightening cream has been used for more than a few months without review.
Any spot that is new, changing in size, shape or colour, has an irregular border, itches or bleeds should be examined by a doctor before it is lasered, because a laser can hide a lesion that needed a biopsy.
Thermal energy is itself a melasma trigger, so a device chosen for the wrong diagnosis, or settings pushed too hard, can drive rebound hyperpigmentation. If pigmentation worsened after a session, the sensible step is reassessment before booking another rather than continuing the same approach.
Melasma is chronic and relapsing, so it is managed rather than removed. An honest plan starts conservatively, addresses heat and UV triggers, and includes daily photoprotection. Response varies between individuals and is assessed in person.
Daily photoprotection is foundational, but UVB and UVA coverage alone does not address visible light, which is also a trigger. Tinted formulations containing iron oxides are commonly used for that reason. Sunscreen is part of management rather than a treatment on its own.
Hormonal influence is well recognised, which is why melasma commonly appears or worsens in pregnancy and with hormonal contraception. That context is part of the history taken at assessment, because it shapes what is realistic to expect from treatment.
It is gradual and needs ongoing care. Aggressive or heat-based laser can darken melasma, repeated toning has been linked to pale spots, and creams can irritate or, if used unsupervised for long, cause bluish-grey discolouration. Oral tranexamic acid is not suitable where clotting risk is raised. Pigment can also return after a flare of triggers.
Question not answered here? Ask on WhatsApp, use the enquiry form, or browse 100 questions patients ask.
Medically reviewed by Dr Sin Yong, MBBS (NUS), MRCS (Edinburgh) · Last reviewed 8 November 2026 · Editorial policy
Consultations by appointment at 9 Scotts Road, Pacific Plaza #12-01, Singapore 228210.
Replies within clinic hours: Mon–Fri 10am–8pm, Sat 11am–3pm · How consultations work · Prefer not to use WhatsApp? · Treatment finder · Call +65 8023 7170 · Map
WhatsApp +65 8023 7170 →